Dendrotoxin-K suppresses tumor growth induced by human lung adenocarcinoma A549 cells in nude mice

Journal of Veterinary Science

Volumn 12, Issue 1, 2011, Pages 35-40

  Jang, Soo Hwa ^a   Ryu, Pan Dong ^a   Lee, So Yeong ^a  

^a Seoul National University   (South Korea)

Author keywords

G1 S transition; Kv1.1; Lung cancer; Voltage gated K+ channels; Xenograft

Indexed keywords

MUS MUSCULUS;

DENDROTOXIN; MESSENGER RNA; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KV1.1; SNAKE VENOM;

ADENOCARCINOMA; ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CELL PROLIFERATION; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; SNAKE; TUMOR CELL LINE; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ELAPID VENOMS; ELAPIDAE; HUMANS; KV1.1 POTASSIUM CHANNEL; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; POTASSIUM CHANNEL BLOCKERS; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS;

EID: 79952098596     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2011.12.1.35     Document Type: Article

References (41)

1. Abdul M, Santo A, Hoosein N. Activity of potassium channel-blockers in breast cancer. Anticancer Res 2003, 23, 3347-3351.
2. + channels in airway and alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2009, 296, L145-155.
3. + channels through an Akt-dependent signaling pathway in breast cancer cells: role in cell proliferation. J Cell Physiol 2007, 212, 690-701.
4. Cai R, Ding X, Zhou K, Shi Y, Ge R, Ren G, Jin Y, Wang Y. Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells. Int J Cancer 2009, 125, 2281-2287.
5. Chittajallu R, Chen Y, Wang H, Yuan X, Ghiani CA, Heckman T, McBain CJ, Gallo V. Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle. Proc Natl Acad Sci USA 2002, 99, 2350-2355.
6. + channels for cancer therapy. J Exp Ther Oncol 2004, 4, 161-166.
7. Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martínez-Mármol R, Solé L, Ferreres JC, Condom E. Potassium channels: new targets in cancer therapy. Cancer Detect Prev 2006, 30, 375-385.
8. Gulbins E, Sassi N, Grassmè H, Zoratti M, Szabò I. Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes. Biochim Biophys Acta 2010, 1797, 1251-1259.
9. Harvey AL. Recent studies on dendrotoxins and potassium ion channels. Gen Pharmacol 1997, 28, 7-12.
10. Hille B. Ion Channels of Excitable Membranes. 3rd ed. pp. 131-167, Sinauer, Sunderland, 2001.
11. Huang L, Li B, Li W, Guo H, Zou F. ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. Carcinogenesis 2009, 30, 737-744.
12. Jacobs JP, Jones CM, Baille JP. Characteristics of a human diploid cell designated MRC-5. Nature 1970, 227, 168-170.
13. Jang SH, Choi C, Hong SG, Yarishkin OV, Bae YM, Kim JG, O'Grady SM, Yoon KA, Kang KS, Ryu PD, Lee SY. Silencing of Kv4.1 potassium channels inhibits cell proliferation of tumorigenic human mammary epithelial cells. Biochem Biophys Res Commun 2009, 384, 180-186.
14. + channel subunit as a potential diagnostic marker and therapeutic target for breast cancer. BMB Rep 2009, 42, 535-539.
15. Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 1999, 39, 295-312.
16. Ca1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene 2009, 28, 1792-1806.
17. Lan M, Shi Y, Han Z, Hao Z, Pan Y, Liu N, Guo C, Hong L, Wang J, Qiao T, Fan D. Expression of delayed rectifier potassium channels and their possible roles in proliferation of human gastric cancer cells. Cancer Biol Ther 2005, 4, 1342-1347.
18. Le Guennec JY, Ouadid-Ahidouch H, Soriani O, Besson P, Ahidouch A, Vandier C. Voltage-gated ion channels, new targets in anti-cancer research. Recent Pat Anticancer Drug Discov 2007, 2, 189-202.
19. + channels that are located in apical membrane. Am J Physiol Cell Physiol 2003, 284, C1614-1624.
20. Nigg EA. Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 1995, 17, 471-480.
21. + channel expression in human breast cancer cells: involvement in cell cycle regulation and carcinogenesis. J Membr Biol 2008, 221, 1-6.
22. + channels identification in human breast carcinoma cells: involvement in cell proliferation. Biochem Biophys Res Commun 2000, 278, 272-277.
23. Pardo LA, Contreras-Jurado C, Zientkowska M, Alves F, Stühmer W. Role of voltage-gated potassium channels in cancer. J Membr Biol 2005, 205, 115-124.
24. Pardo LA, Sühmer W. Eag1 as a cancer target. Expert Opin Ther Targets 2008, 12, 837-843.
25. Rangaraju S, Chi V, Pennington MW, Chandy KG. Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert Opin Ther Targets 2009, 13, 909-924.
26. Roura-Ferrer M, Solé L, Martínez-Mármol R, Villalonga N, Felipe A. Skeletal muscle Kv7 (KCNQ) channels in myoblast differentiation and proliferation. Biochem Biophys Res Commun 2008, 369, 1094-1097.
27. Shao XD, Wu KC, Guo XZ, Xie MJ, Zhang J, Fan DM. Expression and significance of HERG protein in gastric cancer. Cancer Biol Ther 2008, 7, 45-50.
28. Shi Y, Ding X, He ZH, Zhou KC, Wang Q, Wang YZ. Critical role of TRPC6 channels in G2 phase transition and the development of human oesophageal cancer. Gut 2009, 58, 1443-1450.
29. + channels. Biochemistry 1997, 36, 7690-7696.
30. Spencer RH, Chandy KG, Gutman GA. Immunological identification of the Shaker-related Kv1.3 potassium channel protein in T and B lymphocytes, and detection of related proteins in files and yeast. Biochem Biophys Res Commun 1993, 191, 201-206.
31. Stühmer W, Alves F, Hartung F, Zientkowska M, Pardo LA. Potassium channels as tumour markers. FEBS Lett 2006, 580, 2850-2852.
32. Villalonga N, Martínez-Mármol R, Roura-Ferrer M, David M, Valenzuela C, Soler C, Felipe A. Cell cycledependent expression of Kv1.5 is involved in myoblast proliferation. Biochim Biophys Acta 2008, 1783, 728-736.
33. Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, Robinson RB, Cordon-Cardo C, Feinmark SJ. TREK-1 is a novel molecular target in prostate cancer. Cancer Res 2008, 68, 1197-1203.
34. + channels containing Kv1.1 and 1.2 alpha subunits. Eur J Biochem 1999, 263, 222-229.
35. Wu WK, Li GR, Wong HP, Hui MK, Tai EK, Lam EK, Shin VY, Ye YN, Li P, Yang YH, Luo JC, Cho CH. Involvement of Kv1.1 and Nav1.5 in proliferation of gastric epithelial cells. J Cell Physiol 2006, 207, 437-444.
36. Wulff H, Castle NA, Pardo LA. Voltage-gated potassium channels as therapeutic targets. Nat Rev Drug Discov 2009, 8, 982-1001.
37. Yang SL, Cao Q, Zhou KC, Feng YJ, Wang YZ. Transient receptor potential channel C3 contributes to the progression of human ovarian cancer. Oncogene 2009, 28, 1320-1328.
38. Zeng X, Sikka SC, Huang L, Sun C, Xu C, Jia D, Abdel-Mageed AB, Pottle JE, Taylor JT, Li M. Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation. Prostate Cancer Prostatic Dis 2009, 13, 195-201.
39. + channels are associated with cell proliferation and cell cycle of ovarian cancer cell. Gynecol Oncol 2007, 104, 455-460.
40. Zhao J, Wei XL, Jia YS, Zheng JQ. Silencing of herg gene by shRNA inhibits SH-SY5Y cell growth in vitro and in vivo. Eur J Pharmacol 2008, 579, 50-57.
41. + channels inhibits adhesion and proliferation of hepatocarcinoma cells. Int J Mol Med 2003, 11, 261-266.